Table 3.
Time | |||||
---|---|---|---|---|---|
Variables | Groups | RR | 8 h | 24 h | Total |
Analgesics | Group NF (n = 39) | 3 (7.7) | 5 (12.8) | 3 (7.7) | 10 (25.6) |
Group N240 (n = 39) | 6 (15.4) | 6 (15.4) | 5 (12.8) | 15 (38.5) | |
p value | 0.481 | 0.745 | 0.455 | 0.225 | |
Antiemetics * | Group NF (n = 39) | 0 (0) | 6 (15.4) | 0 (0) | 6 (15.4) |
Group N240 (n = 39) | 0 (0) | 2 (5.1) | 0 (0) | 2 (5.1) | |
p value | - | 0.263 | - | 0.263 |
Values are expressed as the number (percentage) of patients [n (%)]. Group NF, group receiving nefopam-fentanyl polytherapy; Group N240, group receiving nefopam monotherapy; RR, 30 min after admission to the recovery room. *: number (percentage) of patients who experienced PONV with NRS score >4.